TY - JOUR AU - Bosset, J. -. F. AU - Collette, L. AU - Calais, G. AU - Mineur, L. AU - Maingon, P. AU - Radosevic-Jelic, L. PY - 2006 DA - 2006// TI - Chemotherapy with preoperative radiotherapy in rectal Cancer JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa060829 DO - 10.1056/NEJMoa060829 ID - Bosset2006 ER - TY - JOUR AU - Rödel, C. AU - Graeven, U. AU - Fietkau, R. AU - Hohenberger, W. AU - Hothorn, T. AU - Arnold, D. PY - 2015 DA - 2015// TI - Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00159-X DO - 10.1016/S1470-2045(15)00159-X ID - Rödel2015 ER - TY - STD TI - Fokas E, Ströbel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, et al. Tumor regression grading after preoperative Chemoradiotherapy as a prognostic factor and individual-level surrogate for disease-free survival in rectal Cancer. J Natl Cancer Inst. 2017;109. https://doi.org/10.1093/jnci/djx095. ID - ref3 ER - TY - JOUR AU - Sharma, R. A. AU - Plummer, R. AU - Stock, J. K. AU - Greenhalgh, T. A. AU - Ataman, O. AU - Kelly, S. PY - 2016 DA - 2016// TI - Clinical development of new drug-radiotherapy combinations JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2016.79 DO - 10.1038/nrclinonc.2016.79 ID - Sharma2016 ER - TY - STD TI - Ahmad SS, Crittenden MR, Tran PT, Kluetz PG, Blumenthal GM, Bulbeck H, et al. Clinical Development of Novel Drug-Radiotherapy Combinations. Clin Cancer Res. 2019;25(5):1455–62. ID - ref5 ER - TY - JOUR AU - Bell, J. C. AU - Garson, K. A. AU - Lichty, B. D. AU - Stojdl, F. D. PY - 2002 DA - 2002// TI - Oncolytic viruses: programmable tumour hunters JO - Curr Gene Ther VL - 2 UR - https://doi.org/10.2174/1566523024605582 DO - 10.2174/1566523024605582 ID - Bell2002 ER - TY - JOUR AU - Parato, K. A. AU - Senger, D. AU - Forsyth, P. A. J. AU - Bell, J. C. PY - 2005 DA - 2005// TI - Recent progress in the battle between oncolytic viruses and tumours JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1750 DO - 10.1038/nrc1750 ID - Parato2005 ER - TY - STD TI - O’Cathail SM, Pokrovska TD, Maughan TS, Fisher KD, Seymour LW, Hawkins MA. Combining Oncolytic adenovirus with radiation—a paradigm for the future of Radiosensitization. Front Oncol. 2017;7. https://doi.org/10.3389/fonc.2017.00153. ID - ref8 ER - TY - JOUR AU - Kaliberov, S. A. AU - Buchsbaum, D. J. PY - 2012 DA - 2012// TI - Cancer treatment with gene therapy and radiation therapy JO - Adv Cancer Res VL - 115 UR - https://doi.org/10.1016/B978-0-12-398342-8.00007-0 DO - 10.1016/B978-0-12-398342-8.00007-0 ID - Kaliberov2012 ER - TY - JOUR AU - Forrester, N. A. AU - Sedgwick, G. G. AU - Thomas, A. AU - Blackford, A. N. AU - Speiseder, T. AU - Dobner, T. PY - 2011 DA - 2011// TI - Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection JO - J Virol VL - 85 UR - https://doi.org/10.1128/JVI.01748-10 DO - 10.1128/JVI.01748-10 ID - Forrester2011 ER - TY - JOUR AU - Dilley, J. AU - Reddy, S. AU - Ko, D. AU - Nguyen, N. AU - Rojas, G. AU - Working, P. PY - 2005 DA - 2005// TI - Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity JO - Cancer Gene Ther VL - 12 UR - https://doi.org/10.1038/sj.cgt.7700835 DO - 10.1038/sj.cgt.7700835 ID - Dilley2005 ER - TY - JOUR AU - Toth, K. AU - Tarakanova, V. AU - Doronin, K. AU - Ward, P. AU - Kuppuswamy, M. AU - Locke, J. E. PY - 2003 DA - 2003// TI - Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein JO - Cancer Gene Ther VL - 10 UR - https://doi.org/10.1038/sj.cgt.7700555 DO - 10.1038/sj.cgt.7700555 ID - Toth2003 ER - TY - JOUR AU - Emdad, L. AU - Sarkar, D. AU - Lebedeva, I. V. AU - Su, Z. -. Z. AU - Gupta, P. AU - Mahasreshti, P. J. PY - 2006 DA - 2006// TI - Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer JO - J Cell Physiol VL - 208 UR - https://doi.org/10.1002/jcp.20663 DO - 10.1002/jcp.20663 ID - Emdad2006 ER - TY - JOUR AU - Geoerger, B. AU - Grill, J. AU - Opolon, P. AU - Morizet, J. AU - Aubert, G. AU - Lecluse, Y. PY - 2003 DA - 2003// TI - Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts JO - Br J Cancer VL - 89 UR - https://doi.org/10.1038/sj.bjc.6601102 DO - 10.1038/sj.bjc.6601102 ID - Geoerger2003 ER - TY - JOUR AU - Kawabe, S. AU - Munshi, A. AU - Zumstein, L. A. AU - Wilson, D. R. AU - Roth, J. A. AU - Meyn, R. E. PY - 2001 DA - 2001// TI - Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts JO - Int J Radiat Biol VL - 77 UR - https://doi.org/10.1080/09553000010008540 DO - 10.1080/09553000010008540 ID - Kawabe2001 ER - TY - JOUR AU - Green, N. K. AU - Herbert, C. W. AU - Hale, S. J. AU - Hale, A. B. AU - Mautner, V. AU - Harkins, R. PY - 2004 DA - 2004// TI - Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus JO - Gene Ther VL - 11 UR - https://doi.org/10.1038/sj.gt.3302295 DO - 10.1038/sj.gt.3302295 ID - Green2004 ER - TY - JOUR AU - Liu, C. AU - Zhang, Y. AU - Liu, M. M. AU - Zhou, H. AU - Chowdhury, W. AU - Lupold, S. E. PY - 2010 DA - 2010// TI - Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer JO - Int J Radiat Biol VL - 86 UR - https://doi.org/10.3109/09553000903419338 DO - 10.3109/09553000903419338 ID - Liu2010 ER - TY - JOUR AU - Freytag, S. O. AU - Movsas, B. AU - Aref, I. AU - Stricker, H. AU - Peabody, J. AU - Pegg, J. PY - 2007 DA - 2007// TI - Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer JO - Mol Ther VL - 15 UR - https://doi.org/10.1038/mt.sj.6300120 DO - 10.1038/mt.sj.6300120 ID - Freytag2007 ER - TY - JOUR AU - Freytag, S. O. AU - Stricker, H. AU - Lu, M. AU - Elshaikh, M. AU - Aref, I. AU - Pradhan, D. PY - 2014 DA - 2014// TI - Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 89 UR - https://doi.org/10.1016/j.ijrobp.2014.02.034 DO - 10.1016/j.ijrobp.2014.02.034 ID - Freytag2014 ER - TY - JOUR AU - Fujita, T. AU - Teh, B. S. AU - Timme, T. L. AU - Mai, W. -. Y. AU - Satoh, T. AU - Kusaka, N. PY - 2006 DA - 2006// TI - Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients JO - Int J Radiat Oncol Biol Phys VL - 65 UR - https://doi.org/10.1016/j.ijrobp.2005.11.009 DO - 10.1016/j.ijrobp.2005.11.009 ID - Fujita2006 ER - TY - JOUR AU - Seiwert, T. Y. AU - Darga, T. AU - Haraf, D. AU - Blair, E. A. AU - Stenson, K. AU - Cohen, E. E. W. PY - 2013 DA - 2013// TI - A phase I dose escalation study of ad GV.EGR.TNF.11D (TNFerade biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mds523 DO - 10.1093/annonc/mds523 ID - Seiwert2013 ER - TY - JOUR AU - Hecht, J. R. AU - Farrell, J. J. AU - Senzer, N. AU - Nemunaitis, J. AU - Rosemurgy, A. AU - Chung, T. PY - 2012 DA - 2012// TI - EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study JO - Gastrointest Endosc VL - 75 UR - https://doi.org/10.1016/j.gie.2011.10.007 DO - 10.1016/j.gie.2011.10.007 ID - Hecht2012 ER - TY - JOUR AU - Swisher, S. G. AU - Roth, J. A. AU - Komaki, R. AU - Gu, J. AU - Lee, J. J. AU - Hicks, M. PY - 2003 DA - 2003// TI - Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy JO - Clin Cancer Res VL - 9 ID - Swisher2003 ER - TY - JOUR AU - Chiocca, E. A. AU - Aguilar, L. K. AU - Bell, S. D. AU - Kaur, B. AU - Hardcastle, J. AU - Cavaliere, R. PY - 2011 DA - 2011// TI - Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.5222 DO - 10.1200/JCO.2011.35.5222 ID - Chiocca2011 ER - TY - JOUR AU - Chen, Y. AU - DeWeese, T. AU - Dilley, J. AU - Zhang, Y. AU - Li, Y. AU - Ramesh, N. PY - 2001 DA - 2001// TI - CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity JO - Cancer Res VL - 61 ID - Chen2001 ER - TY - JOUR AU - Senzer, N. AU - Mani, S. AU - Rosemurgy, A. AU - Nemunaitis, J. AU - Cunningham, C. AU - Guha, C. PY - 2004 DA - 2004// TI - TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.01.227 DO - 10.1200/JCO.2004.01.227 ID - Senzer2004 ER - TY - JOUR AU - Markert, J. M. AU - Razdan, S. N. AU - Kuo, H. C. AU - Cantor, A. AU - Knoll, A. AU - Karrasch, M. PY - 2014 DA - 2014// TI - A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses JO - Mol Ther VL - 22 UR - https://doi.org/10.1038/mt.2014.22 DO - 10.1038/mt.2014.22 ID - Markert2014 ER - TY - JOUR AU - Mundt, A. J. AU - Vijayakumar, S. AU - Nemunaitis, J. AU - Sandler, A. AU - Schwartz, H. AU - Hanna, N. PY - 2004 DA - 2004// TI - A phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-0296 DO - 10.1158/1078-0432.CCR-04-0296 ID - Mundt2004 ER - TY - JOUR AU - Kuhn, I. AU - Harden, P. AU - Bauzon, M. AU - Chartier, C. AU - Nye, J. AU - Thorne, S. PY - 2008 DA - 2008// TI - Directed evolution generates a novel Oncolytic virus for the treatment of Colon Cancer JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0002409 DO - 10.1371/journal.pone.0002409 ID - Kuhn2008 ER - TY - JOUR AU - Dyer, A. AU - Di, Y. AU - Calderon, H. AU - Illingworth, S. AU - Kueberuwa, G. AU - Tedcastle, A. PY - 2016 DA - 2016// TI - Oncolytic group B adenovirus Enadenotucirev mediates non-apoptotic cell death with membrane disruption and release of inflammatory mediators JO - Mol Ther Oncolytics VL - 4 UR - https://doi.org/10.1016/j.omto.2016.11.003 DO - 10.1016/j.omto.2016.11.003 ID - Dyer2016 ER - TY - JOUR AU - Garcia-Carbonero, R. AU - Salazar, R. AU - Duran, I. AU - Osman-Garcia, I. AU - Paz-Ares, L. AU - Bozada, J. M. PY - 2017 DA - 2017// TI - Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection JO - J ImmunoTher Cancer VL - 5 UR - https://doi.org/10.1186/s40425-017-0277-7 DO - 10.1186/s40425-017-0277-7 ID - Garcia-Carbonero2017 ER - TY - STD TI - Machiels J-P, Salazar R, Rottey S, Duran I, Dirix L, Geboes K, et al. A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE). J Immunother Cancer. 2019;7. https://doi.org/10.1186/s40425-019-0510-7. ID - ref32 ER - TY - JOUR AU - Sauer, R. AU - Becker, H. AU - Hohenberger, W. AU - Rödel, C. AU - Wittekind, C. AU - Fietkau, R. PY - 2004 DA - 2004// TI - Preoperative versus postoperative Chemoradiotherapy for rectal Cancer JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa040694 DO - 10.1056/NEJMoa040694 ID - Sauer2004 ER - TY - JOUR AU - Ansari, N. AU - Solomon, M. J. AU - Fisher, R. J. AU - Mackay, J. AU - Burmeister, B. AU - Ackland, S. PY - 2017 DA - 2017// TI - Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04) JO - Ann Surg VL - 265 UR - https://doi.org/10.1097/SLA.0000000000001987 DO - 10.1097/SLA.0000000000001987 ID - Ansari2017 ER - TY - JOUR AU - George, T. J. AU - Allegra, C. J. AU - Yothers, G. PY - 2015 DA - 2015// TI - Neoadjuvant rectal (NAR) score: a new surrogate endpoint in rectal Cancer clinical trials JO - Curr Colorectal Cancer Rep VL - 11 UR - https://doi.org/10.1007/s11888-015-0285-2 DO - 10.1007/s11888-015-0285-2 ID - George2015 ER - TY - JOUR AU - Cheung, Y. K. AU - Chappell, R. PY - 2000 DA - 2000// TI - Sequential designs for phase I clinical trials with late-onset toxicities JO - Biometrics. VL - 56 UR - https://doi.org/10.1111/j.0006-341X.2000.01177.x DO - 10.1111/j.0006-341X.2000.01177.x ID - Cheung2000 ER - TY - JOUR AU - Neuenschwander, B. AU - Branson, M. AU - Gsponer, T. PY - 2008 DA - 2008// TI - Critical aspects of the Bayesian approach to phase I cancer trials JO - Stat Med VL - 27 UR - https://doi.org/10.1002/sim.3230 DO - 10.1002/sim.3230 ID - Neuenschwander2008 ER - TY - JOUR AU - Ngan, S. Y. K. AU - Michael, M. AU - Mackay, J. AU - McKendrick, J. AU - Leong, T. AU - Lim Joon, D. PY - 2004 DA - 2004// TI - A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer JO - Br J Cancer VL - 91 UR - https://doi.org/10.1038/sj.bjc.6602106 DO - 10.1038/sj.bjc.6602106 ID - Ngan2004 ER - TY - JOUR AU - Greenhalgh, T. A. AU - Dearman, C. AU - Sharma, R. A. PY - 2016 DA - 2016// TI - Combination of novel agents with radiotherapy to treat rectal Cancer JO - Clin Oncol VL - 28 UR - https://doi.org/10.1016/j.clon.2015.11.002 DO - 10.1016/j.clon.2015.11.002 ID - Greenhalgh2016 ER - TY - JOUR AU - Teo, M. T. W. AU - McParland, L. AU - Appelt, A. L. AU - Sebag-Montefiore, D. PY - 2018 DA - 2018// TI - Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review JO - Int J Radiation Oncol Biol Physics VL - 100 UR - https://doi.org/10.1016/j.ijrobp.2017.09.042 DO - 10.1016/j.ijrobp.2017.09.042 ID - Teo2018 ER - TY - JOUR AU - Czito, B. G. AU - Deming, D. A. AU - Jameson, G. S. AU - Mulcahy, M. F. AU - Vaghefi, H. AU - Dudley, M. W. PY - 2017 DA - 2017// TI - Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study JO - Lancet Gastroenterol Hepatol VL - 2 UR - https://doi.org/10.1016/S2468-1253(17)30012-2 DO - 10.1016/S2468-1253(17)30012-2 ID - Czito2017 ER - TY - JOUR AU - Fokas, E. AU - Fietkau, R. AU - Hartmann, A. AU - Hohenberger, W. AU - Grützmann, R. AU - Ghadimi, M. PY - 2018 DA - 2018// TI - Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial JO - Ann Oncol VL - 29 UR - https://doi.org/10.1093/annonc/mdy143 DO - 10.1093/annonc/mdy143 ID - Fokas2018 ER -